My research focus centres around the pathophysiology and treatment of resistant hypertension – patients who despite having more than three drug classes still have elevated blood pressure. I am a microneurographer by training, performing and interpreting direct nerve recordings of sympathetic fibres in humans to better understand sympathetic control of blood pressure in this cohort. Much of my work has been in renal denervation – the ablation of the renal nerves to reduce blood pressure in patients with treatment-resistant or complex to manage hypertension. My work has focussed on the long-term outcomes of the procedure and shown the blood pressure lowering effect persists well beyond the clinical trial period with patients on less antihypertensive medications with no adverse consequences for the kidneys. However, I’ve been lucky enough to be involved in diverse areas of hypertension research including the microbiome, novel brain networks controlling blood pressure, and cardiovascular reflexes. I’ve also had the pleasure to lead blood pressure screenings with May Measurement Month across Victoria, work towards improved blood pressure screening as a National Hypertension Taskforce Working Group Member and now excitingly be serving as the Director for Strategy and Communications for Hypertension Australia.